International collaboration to investigate diabetes epigenetics

L-R: Professor Mark Cooper (Monash), Professor Stephen Jane 
(Monash), Professor Paul Zimmet (Monash), Mr Sami Sagol,
Professor Naftali Stern (Director of Endocrinology,Tel Aviv
Medical Center), Dr Tamar Shahal, Prof Sam El-Osta (Monash)

A new Israel-Australia research centre involving a major collaboration with Monash University was officially launched 5 September 2018 in Tel Aviv, Israel.

The Sagol Center for Epigenetics of Metabolism and Aging cements the relationship between Monash University and the Tel Aviv Medical Center, Israel’s largest health institution, where the centre will be based. The initiative was made possible by the generosity of the Sagol family in Israel and is the vision of philanthropist Sami Sagol.

New Tel Aviv-Monash research centre for metabolic disorders

L-R: Professor Paul Zimmet (Monash); Dr Ronni Gamzu (CEO, Tel Aviv
Medical Center); Mr Sami Sagol (philanthropist); Professor Naftali Stern
(Director of Endocrinology, Tel Aviv Medical Center)

A major research collaboration between the new Department of Diabetes at Monash University and the newly established Sagol Center for Epigenetics of Metabolism and Aging at Tel Aviv Medical Center was announced in Israel on 26 May 2017. This generous initiative was made possible by the Sagol family.

The Center is part of a network of research centres established in academic and medical centres by the Sagol family, focusing on the advancement of research on longevity and quality of life.